EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deletion of neuronal Idol ameliorates Alzheimer's disease–related pathologies via APOE receptors

Hande Karahan, Kelly Hartigan, Md Mamun Al-Amin, Sutha K John, Brianne McCord, H R Sagara Wijeratne, Dominic J Acri, Daniel C Smith, Luke C Dabin, Hannah M Rondon Cordero, Byungwook Kim, Do-Hun Lee und 1 weitere

Alzheimer's & Dementia · 2025-12 · 21 (12)

DOI: 10.1002/alz.70949 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.12.2025. Verfasst von Hande Karahan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurons, Apolipoproteins E, Receptors, LDL. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Association, Indiana University Precision Health Initiative, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Overexpression of the low‐density lipoprotein receptor (LDLR) is known to decrease apolipoprotein E (APOE) levels and alleviate amyloid beta (Aβ) pathology. We hypothesized that inhibiting the Inducible Degrader of LDLR (IDOL), an enzyme that ubiquitinates LDLR for degradation, would increase endogenous LDLR levels and attenuate amyloid pathology. METHODS To investigate the cell‐type–specific role of IDOL, we generated Idol conditional knockout mice on an Aβ‐amyloidosis mouse model and performed biochemical, histological, and multi‐omics analyses. RESULTS We demonstrated that neuronal, but not microglial, Idol deletion reduced amyloid accumulation and altered brain LDLR and APOE levels, indicating the critical role of neuronal IDOL‐LDLR in amyloid pathology. In addition, neuronal Idol deletion increased the levels of Reelin receptors important for synaptic function, and single‐nuclei RNA sequencing revealed significant changes associated with synaptic organization. DISCUSSION Neuronal IDOL, but not microglial IDOL, plays a key role in Alzheimer's disease pathogenesis by regulating the levels of brain APOE receptors. Highlights Neuronal, but not microglial, Idol deletion reduces amyloid burden and modulates brain APOE and LDLR levels. Deletion of neuronal Idol increases the levels of APOER2 and VLDLR, the Reelin receptors, in the brain. Single‐nuclei RNA sequencing highlights the neuronal IDOL's impact on inhibitory neurons and synaptic organization. Targeting neuronal IDOL may provide multiple therapeutic benefits in Alzheimer's disease by modulating APOE receptors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuronsApolipoproteins EReceptors, LDLBrainUbiquitin-Protein LigasesAnimalsMiceMice, KnockoutReelin ProteinDisease Models, AnimalAmyloid beta-PeptidesMicroglia

Stichwörter der Autor:innen

APOEAPOER2 (LRP8)Amyloid betaIDOL (MYLIP)LDLRVLDLR

Substanzen

Apolipoproteins EReelin ProteinReceptors, LDLAmyloid beta-PeptidesMylip protein, mouseReln protein, mouseUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Förderung

  • Alzheimer's Association
  • Indiana University Precision Health Initiative
  • NIA NIH HHS
  • Indiana University Strategic Research Initiative
  • NIDDK NIH HHS
  • National Institute on Aging

Zitieren

APA

Karahan, H., Hartigan, K., Al-Amin, M. M., John, S. K., McCord, B., Wijeratne, H. R. S., Acri, D. J., Smith, D. C., Dabin, L. C., Cordero, H. M. R., Kim, B., Lee, D. H., & Kim, J. (2025). Deletion of neuronal Idol ameliorates Alzheimer's disease–related pathologies via APOE receptors. Alzheimer's & Dementia, 21(12). https://doi.org/10.1002/alz.70949

Vancouver

Karahan H, Hartigan K, Al-Amin MM, John SK, McCord B, Wijeratne HRS, et al. Deletion of neuronal Idol ameliorates Alzheimer's disease–related pathologies via APOE receptors. Alzheimer's & Dementia. 2025;21(12). doi:10.1002/alz.70949

BibTeX
@article{Karahan2025,
  author = {Karahan, Hande and Hartigan, Kelly and Al-Amin, Md Mamun and John, Sutha K and McCord, Brianne and Wijeratne, H R Sagara and Acri, Dominic J and Smith, Daniel C and Dabin, Luke C and Cordero, Hannah M Rondon and Kim, Byungwook and Lee, Do-Hun and Kim, Jungsu},
  title = {Deletion of neuronal Idol ameliorates Alzheimer's disease–related pathologies via APOE receptors},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {12},
  doi = {10.1002/alz.70949}
}
Kostenlos starten →